Press Release: AmacaThera : New opioid-alternative raises $3.25 million for Phase I trials

TORONTO, Jan. 11, 2019 /PRNewswire/ -- AmacaThera, a Toronto-based company commercializing hydrogel-based drug delivery platforms, has already raised $3.25 million (CAD) in seed financing from Sprout BioVentures, Viva Biotech, and Grey Sky Venture Partners and welcomes additional...